Sunday, November 10, 2019
- 9:00AM-11:00AM
-
Abstract Number: 318
Improving Safe Prescribing of Hydroxychloroquine in a Safety Net Hospital Rheumatology Clinic
Measures Of Healthcare Quality Poster I: Testing, Screening, & Treating- 9:00AM-11:00AM
-
Abstract Number: 315
Improving the Rate of Tuberculosis Screening Among High Risk Rheumatoid Arthritis Patients on Biologic Agents Using a Proposed Questionnaire
Measures Of Healthcare Quality Poster I: Testing, Screening, & Treating- 9:00AM-11:00AM
-
Abstract Number: 298
In CCP Positive “At Risk of Rheumatoid Arthritis” Individuals, the Presence of Sub-clinical Synovitis in 4-10joints Universally Results in Clinical Synovitis
Imaging Of Rheumatic Diseases Poster I- 9:00AM-11:00AM
-
Abstract Number: 290
In Psoriatic Arthritis Patients Considered in Remission by Their Rheumatologist, Can Discordance in Disease Activity Assessment Between Patient and Rheumatologist Be Explained by Residual Inflammation as Measured by Ultrasonographic Examination?
Imaging Of Rheumatic Diseases Poster I- 9:00AM-11:00AM
-
Abstract Number: 58
In Rheumatoid Arthritis (RA) Decreases in Conventional Dendritic Cell Lineages Are Associated with Adverse Measures of Myocardial Function and Expansions of Anomalous HLA-DR+ Myeloid Subsets
RA – Etiology & Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 552
In the Real World Clinical Setting Etanercept Biosimilar SB4(BENEPAIL®) Demonstrates Equivalent Safety and Effectiveness in Biological Naïve as Well as with ENBREL® Pretreated RA,SPA, and PSA Patients
RA – Treatments Poster I: Novel Treatments- 9:00AM-11:00AM
-
Abstract Number: 113
In Vitro Characterization of the Effect of Cenerimod, a Potent and Selective Sphingosine 1-Phosphate Receptor 1 (S1P1) Modulator, on S1P1 Receptor Expression, Receptor Internalization, and Migration of Primary Human T Cells in the Presence or Absence of Glucocorticoids
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 121
In Vitro Human Enthesitis Model with Induced IL-17A and TNFα from CD4+ and CD8+ T Cells and Effect of Pharmacological Antagonism with Janus Kinase and Retinoic Acid Receptor-related Orphan Receptor γ Inhibition
T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 68
Inactivation of Transaldolase and HRES-1/Rab4 Predisposes to Hepatitis in a Mouse Model of Systemic Lupus Erythematosus
SLE – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 332
Incident Gout After Renal Transplantation in Gout-naïve Patients: Large Database Analysis
Metabolic & Crystal Arthropathies Poster I: Clinical- 9:00AM-11:00AM
-
Abstract Number: 453
Including Pain, Fatigue and Functionality Regularly in the Assessment of Patients with Early Rheumatoid Arthritis Separately Adds to the Evaluation of Disease Status
RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis- 9:00AM-11:00AM
-
Abstract Number: 340
Increased Physical Activity in Gout Patients Correlates with Better Prognosis, Decreased Pain, and Suppressed C-Reactive Protein Levels
Metabolic & Crystal Arthropathies Poster I: Clinical- 9:00AM-11:00AM
-
Abstract Number: 587
Increased Prevalence of Cardiac Disorders in Dutch Ankylosing Spondylitis Patients: The CARDAS Study
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features- 9:00AM-11:00AM
-
Abstract Number: 26
Increased Sodium Accumulation Detected by 23Na-Magnetic Resonance Imaging in Inflamed Knees of Patients with Autoimmune Joint Disease